Clinical Trials Browser

Phase 2 × Hereditary Sensory and Autonomic Neuropathies × Dermatologic × Clear all

NCT01320085 2024-01-24

A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma

Phase 2 Completed

183 enrolled 35 charts

Melanoma, Hereditary Sensory and Autonomic Neuropathies

NCT01942993 2020-09-30

The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

Phase 2 Terminated

3 enrolled 2 charts

Melanoma, Hereditary Sensory and Autonomic Neuropathies